Wilmington, Delaware-based Incyte Corporation (INCY) is a biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutics in the United States and internationally. The company has a market cap of $19.6 billion and offers JAKAFI for the treatment of myelofibrosis, ICLUSIG, a kinase inhibitor for the treatment of chronic myeloid leukemia, and other products.
Companies with a market cap of $10 billion or more are typically referred to as "big-cap stocks." INCY fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the biotechnology industry.
Dear Microsoft Stock Fans, Mark Your Calendars for June 30
Dear Walmart Stock Fans, Mark Your Calendars for June 22
Nothing Seems to Be Going Right for Meta Platforms. How to Play META Stock Here.
Companies with a market cap of $10 billion or more are typically referred to as "big-cap stocks." INCY fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the biotechnology industry.
Dear Microsoft Stock Fans, Mark Your Calendars for June 30
Dear Walmart Stock Fans, Mark Your Calendars for June 22
Nothing Seems to Be Going Right for Meta Platforms. How to Play META Stock Here.
4 months ago
